Figure 2.
Figure 2. Survival in patients on Consortium Protocol DFCI 9501. (A) Event-free survival of TEL/AML1-positive compared with TEL/AML1-negative patients. (B) Overall survival of TEL/AML1-positive compared with TEL/AML1-negative patients.

Survival in patients on Consortium Protocol DFCI 9501. (A) Event-free survival of TEL/AML1-positive compared with TEL/AML1-negative patients. (B) Overall survival of TEL/AML1-positive compared with TEL/AML1-negative patients.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal